-
1
-
-
37749020600
-
Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues
-
1:STN:280:DC%2BD2sjksVGntQ%3D%3D 18079297
-
Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79(1):6-11.
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, Issue.1
, pp. 6-11
-
-
Logroscino, G.1
Traynor, B.J.2
Hardiman, O.3
Chio, A.4
Couratier, P.5
Mitchell, J.D.6
-
2
-
-
84929184539
-
Population ancestral origin in Amyotrophic Lateral Sclerosis incidence, phenotype, and outcome
-
Marin B, Boumediene F, Logroscino G, Labrunie A, Babron MC, Leutenneger AL. Population ancestral origin in Amyotrophic Lateral Sclerosis incidence, phenotype, and outcome. J Neurol Neurosurg Psychiatry. 2015. This meta-analysis reports main aspects of ALS incidence and phenotype produced to date by worldwide population-based studies (fALS, age at onset and diagnosis, sex ratio, bulbar onset, comorbidities, survival time) and considers variations by sub-continents.
-
(2015)
J Neurol Neurosurg Psychiatry
-
-
Marin, B.1
Boumediene, F.2
Logroscino, G.3
Labrunie, A.4
Babron, M.C.5
Leutenneger, A.L.6
-
3
-
-
77950612903
-
Incidence of amyotrophic lateral sclerosis in Europe
-
Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81(4):385-90. This is the first collaborative collection of incident cases of population- based studies in Europe.
-
(2010)
J Neurol Neurosurg Psychiatry.
, vol.81
, Issue.4
, pp. 385-390
-
-
Logroscino, G.1
Traynor, B.J.2
Hardiman, O.3
Chio, A.4
Mitchell, D.5
Swingler, R.J.6
-
4
-
-
0029160951
-
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection
-
1:STN:280:DyaK28%2FpvVKisQ%3D%3D 8543950
-
Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995;132(2):207-15.
-
(1995)
J Neurol Sci
, vol.132
, Issue.2
, pp. 207-215
-
-
Lee, J.R.1
Annegers, J.F.2
Appel, S.H.3
-
5
-
-
84855410186
-
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS
-
22214350
-
Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, et al. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler. 2012;13(1):1-10.
-
(2012)
Amyotroph Lateral Scler
, vol.13
, Issue.1
, pp. 1-10
-
-
Otto, M.1
Bowser, R.2
Turner, M.3
Berry, J.4
Brettschneider, J.5
Connor, J.6
-
6
-
-
84886736202
-
Diagnosis pathway for patients with amyotrophic lateral sclerosis: Retrospective analysis of the US Medicare longitudinal claims database
-
4029731 24499173
-
Williams JR, Fitzhenry D, Grant L, Martyn D, Kerr DA. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. BMC Neurol. 2013;13:160.
-
(2013)
BMC Neurol
, vol.13
, pp. 160
-
-
Williams, J.R.1
Fitzhenry, D.2
Grant, L.3
Martyn, D.4
Kerr, D.A.5
-
7
-
-
0028142392
-
El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial »clinical Limits of Amyotrophic Lateral Sclerosis» Workshop Contributors
-
Brooks BR. El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial »Clinical Limits of Amyotrophic Lateral Sclerosis» Workshop Contributors. J Neurol Sci. 1994;124:Suppl:96-107.
-
(1994)
J Neurol Sci
, vol.124
, pp. 96-107
-
-
Brooks, B.R.1
-
8
-
-
84868585557
-
Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: A systematic review
-
22892641
-
Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol. 2012;69(11):1410-6.
-
(2012)
Arch Neurol
, vol.69
, Issue.11
, pp. 1410-1416
-
-
Costa, J.1
Swash, M.2
De Carvalho, M.3
-
9
-
-
84857537860
-
A proposed staging system for amyotrophic lateral sclerosis
-
3286327 22271664
-
Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135(Pt 3):847-52.
-
(2012)
Brain
, vol.135
, Issue.PART 3
, pp. 847-852
-
-
Roche, J.C.1
Rojas-Garcia, R.2
Scott, K.M.3
Scotton, W.4
Ellis, C.E.5
Burman, R.6
-
10
-
-
84919730632
-
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
-
24336810
-
Chio A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(1):38-44.
-
(2015)
J Neurol Neurosurg Psychiatry
, vol.86
, Issue.1
, pp. 38-44
-
-
Chio, A.1
Hammond, E.R.2
Mora, G.3
Bonito, V.4
Filippini, G.5
-
11
-
-
40849083833
-
Predictors of long survival in amyotrophic lateral sclerosis: A population-based study
-
18021808
-
Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci. 2008;268(1-2):28-32.
-
(2008)
J Neurol Sci
, vol.268
, Issue.1-2
, pp. 28-32
-
-
Zoccolella, S.1
Beghi, E.2
Palagano, G.3
Fraddosio, A.4
Guerra, V.5
Samarelli, V.6
-
12
-
-
84155172791
-
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study
-
21836033
-
Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102-8.
-
(2012)
J Neurol Neurosurg Psychiatry
, vol.83
, Issue.1
, pp. 102-108
-
-
Phukan, J.1
Elamin, M.2
Bede, P.3
Jordan, N.4
Gallagher, L.5
Byrne, S.6
-
13
-
-
79961149076
-
Nutritional assessment and survival in ALS patients
-
1:STN:280:DC%2BD3MvhvVyiug%3D%3D 11467055
-
Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(2):91-6.
-
(2000)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.1
, Issue.2
, pp. 91-96
-
-
Desport, J.C.1
Preux, P.M.2
Truong, C.T.3
Courat, L.4
Vallat, J.M.5
Couratier, P.6
-
14
-
-
33744816556
-
Hypermetabolism in ALS: Correlations with clinical and paraclinical parameters
-
16909026
-
Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2(3-4):202-7.
-
(2005)
Neurodegener Dis
, vol.2
, Issue.3-4
, pp. 202-207
-
-
Desport, J.C.1
Torny, F.2
Lacoste, M.3
Preux, P.M.4
Couratier, P.5
-
15
-
-
62549123753
-
High metabolic level in patients with familial amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BD1MXjtVyhurw%3D 18792852
-
Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(2):113-7.
-
(2009)
Amyotroph Lateral Scler
, vol.10
, Issue.2
, pp. 113-117
-
-
Funalot, B.1
Desport, J.C.2
Sturtz, F.3
Camu, W.4
Couratier, P.5
-
16
-
-
0033595524
-
Nutritional status is a prognostic factor for survival in ALS patients
-
1:STN:280:DyaK1MvisVGrtw%3D%3D 10496266
-
Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059-63.
-
(1999)
Neurology
, vol.53
, Issue.5
, pp. 1059-1063
-
-
Desport, J.C.1
Preux, P.M.2
Truong, T.C.3
Vallat, J.M.4
Sautereau, D.5
Couratier, P.6
-
17
-
-
41349122697
-
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BD1cXjs1Kjtro%3D 18199832
-
Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004-9.
-
(2008)
Neurology
, vol.70
, Issue.13
, pp. 1004-1009
-
-
Dupuis, L.1
Corcia, P.2
Fergani, A.3
Gonzalez De Aguilar, J.L.4
Bonnefont-Rousselot, D.5
Bittar, R.6
-
18
-
-
73449097789
-
Lower serum lipid levels are related to respiratory impairment in patients with ALS
-
1:CAS:528:DC%2BD1MXhtlyrtLzP 19917991
-
Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009;73(20):1681-5.
-
(2009)
Neurology
, vol.73
, Issue.20
, pp. 1681-1685
-
-
Chio, A.1
Calvo, A.2
Ilardi, A.3
Cavallo, E.4
Moglia, C.5
Mutani, R.6
-
19
-
-
79955756864
-
Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients
-
Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628-34. This work investigated for the first time the relation between weight loss at time of diagnosis and survival, highlighting the importance to consider nutritional aspects as soon as possible.
-
(2011)
J Neurol Neurosurg Psychiatry.
, vol.82
, Issue.6
, pp. 628-634
-
-
Marin, B.1
Desport, J.C.2
Kajeu, P.3
Jesus, P.4
Nicolaud, B.5
Nicol, M.6
-
20
-
-
84862985282
-
Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: A cross-sectional study
-
Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012;51(12):1501-8.
-
(2012)
Intern Med.
, vol.51
, Issue.12
, pp. 1501-1508
-
-
Ikeda, K.1
Hirayama, T.2
Takazawa, T.3
Kawabe, K.4
Iwasaki, Y.5
-
21
-
-
0031929662
-
Prognostic indicators of survival in ALS ALS CNTF Treatment Study Group
-
1:STN:280:DyaK1c7gtlKqtA%3D%3D 9443459
-
Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS ALS CNTF Treatment Study Group. Neurology. 1998;50(1):66-72.
-
(1998)
Neurology
, vol.50
, Issue.1
, pp. 66-72
-
-
Stambler, N.1
Charatan, M.2
Cedarbaum, J.M.3
-
22
-
-
0037047014
-
Early symptom progression rate is related to ALS outcome: A prospective population-based study
-
1:STN:280:DC%2BD38zmtVOluw%3D%3D 12105314
-
Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59(1):99-103.
-
(2002)
Neurology
, vol.59
, Issue.1
, pp. 99-103
-
-
Chio, A.1
Mora, G.2
Leone, M.3
Mazzini, L.4
Cocito, D.5
Giordana, M.T.6
-
23
-
-
70450180994
-
Prognostic factors in ALS: A critical review
-
3515205 19922118
-
Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-23.
-
(2009)
Amyotroph Lateral Scler
, vol.10
, Issue.5-6
, pp. 310-323
-
-
Chio, A.1
Logroscino, G.2
Hardiman, O.3
Swingler, R.4
Mitchell, D.5
Beghi, E.6
-
24
-
-
12744277960
-
Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis
-
15516537
-
Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171(3):269-74.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, Issue.3
, pp. 269-274
-
-
Morgan, R.K.1
McNally, S.2
Alexander, M.3
Conroy, R.4
Hardiman, O.5
Costello, R.W.6
-
25
-
-
84925515352
-
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis
-
This work investigated various methods of investigation respiratory function. It identified Sniff test as the best predictor of death or tracheostomy within 1 year of follow-up
-
Capozzo R, Quaranta VN, Pellegrini F, Fontana A, Copetti M, Carratu P, et al. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis. J Neurol. 2014. This work investigated various methods of investigation respiratory function. It identified Sniff test as the best predictor of death or tracheostomy within 1 year of follow-up.
-
(2014)
J Neurol.
-
-
Capozzo, R.1
Quaranta, V.N.2
Pellegrini, F.3
Fontana, A.4
Copetti, M.5
Carratu, P.6
-
26
-
-
30344479450
-
Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design
-
16258948
-
Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33(1):127-32.
-
(2006)
Muscle Nerve
, vol.33
, Issue.1
, pp. 127-132
-
-
Schmidt, E.P.1
Drachman, D.B.2
Wiener, C.M.3
Clawson, L.4
Kimball, R.5
Lechtzin, N.6
-
27
-
-
84857044928
-
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - Revised report of an EFNS task force
-
21914052
-
Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360-75.
-
(2012)
Eur J Neurol
, vol.19
, Issue.3
, pp. 360-375
-
-
Andersen, P.M.1
Abrahams, S.2
Borasio, G.D.3
De Carvalho, M.4
Chio, A.5
Van Damme, P.6
-
28
-
-
70350149848
-
Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
2764727 1:STN:280:DC%2BD1Mnos1Sitg%3D%3D 19822872
-
Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218-26.
-
(2009)
Neurology
, vol.73
, Issue.15
, pp. 1218-1226
-
-
Miller, R.G.1
Jackson, C.E.2
Kasarskis, E.J.3
England, J.D.4
Forshew, D.5
Johnston, W.6
-
29
-
-
0028845946
-
Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis
-
Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242(10):695-8.
-
(1995)
J Neurol.
, vol.242
, Issue.10
, pp. 695-698
-
-
Mazzini, L.1
Corrà, T.2
Zaccala, M.3
Mora, G.4
Del Piano, M.5
Galante, M.6
-
30
-
-
84866083418
-
First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin
-
Jesus P, Massoulard A, Marin B, Nicol M, Laplagne O, Baptiste A, Gindre-Poulvelarie L, Couratier P, Fraysse JL, Desport JC. First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin. Amyotroph Lateral Scler. 2012;13(6):538-43.
-
(2012)
Amyotroph Lateral Scler.
, vol.13
, Issue.6
, pp. 538-543
-
-
Jesus, P.1
Massoulard, A.2
Marin, B.3
Nicol, M.4
Laplagne, O.5
Baptiste, A.6
Gindre-Poulvelarie, L.7
Couratier, P.8
Fraysse, J.L.9
Desport, J.C.10
-
31
-
-
68349157123
-
Hypermetabolism in ALS patients: An early and persistent phenomenon
-
Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256(8):1236-42.
-
(2009)
J Neurol.
, vol.256
, Issue.8
, pp. 1236-1242
-
-
Bouteloup, C.1
Desport, J.C.2
Clavelou, P.3
Guy, N.4
Derumeaux-Burel, H.5
Ferrier, A.6
Couratier, P.7
-
32
-
-
0031696116
-
Indicators and prevalence of malnutrition in motor neurone disease
-
Worwood AM, Leigh PN. Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol. 1998;40(3):159-63.
-
(1998)
Eur Neurol.
, vol.40
, Issue.3
, pp. 159-163
-
-
Worwood, A.M.1
Leigh, P.N.2
-
33
-
-
77956676420
-
Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS
-
Limousin N, Blasco H, Corcia P, Gordon PH, De Toffol B, Andres C, Praline J. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci. 2010;297(1-2):36-9.
-
(2010)
J Neurol Sci.
, vol.297
, Issue.1-2
, pp. 36-39
-
-
Limousin, N.1
Blasco, H.2
Corcia, P.3
Gordon, P.H.4
De Toffol, B.5
Andres, C.6
Praline, J.7
-
34
-
-
0020966374
-
Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS)
-
Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc. 1983;83(1):44-7.
-
(1983)
J Am Diet Assoc.
, vol.83
, Issue.1
, pp. 44-47
-
-
Slowie, L.A.1
Paige, M.S.2
Antel, J.P.3
-
36
-
-
84908663721
-
Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - The French register of ALS in Limousin (FRALim register)
-
Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe - the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21(10):1292-300. This work performed in a region of France characterized by an old population (30% of subjects older than 60 years) identified a crude ALS incidence as high as 3.2/100,000 person-year of follow-up.
-
(2014)
Eur J Neurol.
, vol.21
, Issue.10
, pp. 1292-1300
-
-
Marin, B.1
Hamidou, B.2
Couratier, P.3
Nicol, M.4
Delzor, A.5
Raymondeau, M.6
-
37
-
-
84877851029
-
Amyotrophic lateral sclerosis in Catalonia: A population based study
-
23286747
-
Pradas J, Puig T, Rojas-Garcia R, Viguera ML, Gich I, Logroscino G. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(4):278-83.
-
(2013)
Amyotroph Lateral Scler Frontotemporal Degener
, vol.14
, Issue.4
, pp. 278-283
-
-
Pradas, J.1
Puig, T.2
Rojas-Garcia, R.3
Viguera, M.L.4
Gich, I.5
Logroscino, G.6
-
38
-
-
84860362784
-
Incidence of amyotrophic lateral sclerosis in Sicily: A population based study
-
22409362
-
Ragonese P, Cellura E, Aridon P, D'Amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13(3):284-7.
-
(2012)
Amyotroph Lateral Scler
, vol.13
, Issue.3
, pp. 284-287
-
-
Ragonese, P.1
Cellura, E.2
Aridon, P.3
D'Amelio, M.4
Spataro, R.5
Taiello, A.C.6
-
39
-
-
23144445291
-
Incidence of amyotrophic lateral sclerosis in southern Italy: A population based study
-
1739746 1:STN:280:DC%2BD2Mzms1ymtg%3D%3D 16024886
-
Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76(8):1094-8.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, Issue.8
, pp. 1094-1098
-
-
Logroscino, G.1
Beghi, E.2
Zoccolella, S.3
Palagano, R.4
Fraddosio, A.5
Simone, I.L.6
-
40
-
-
1542329664
-
The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over
-
14960427
-
Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing. 2004;33(2):131-4.
-
(2004)
Age Ageing
, vol.33
, Issue.2
, pp. 131-134
-
-
Forbes, R.B.1
Colville, S.2
Swingler, R.J.3
-
41
-
-
79955774490
-
Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis
-
21047878
-
Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(6):623-7.
-
(2011)
J Neurol Neurosurg Psychiatry
, vol.82
, Issue.6
, pp. 623-627
-
-
Byrne, S.1
Walsh, C.2
Lynch, C.3
Bede, P.4
Elamin, M.5
Kenna, K.6
-
42
-
-
84892145247
-
Familial clustering of ALS in a population-based resource
-
3873619 24306004
-
Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L. Familial clustering of ALS in a population-based resource. Neurology. 2014;82(1):17-22.
-
(2014)
Neurology
, vol.82
, Issue.1
, pp. 17-22
-
-
Gibson, S.B.1
Figueroa, K.P.2
Bromberg, M.B.3
Pulst, S.M.4
Cannon-Albright, L.5
-
43
-
-
67049118072
-
Reduced frequency of ALS in an ethnically mixed population: A population-based mortality study
-
1:STN:280:DC%2BD1MzjslOgsw%3D%3D 19433736
-
Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72(19):1640-5.
-
(2009)
Neurology
, vol.72
, Issue.19
, pp. 1640-1645
-
-
Zaldivar, T.1
Gutierrez, J.2
Lara, G.3
Carbonara, M.4
Logroscino, G.5
Hardiman, O.6
-
44
-
-
84885781946
-
Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009
-
Seals RM, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. Am J Epidemiol. 2013;178(8):1265-71. This age-period-cohort analysis identified a 2% annual increment in the adjusted incidence of ALS in Denmark. Consistent results were obtained for mortality rates.
-
(2013)
Am J Epidemiol.
, vol.178
, Issue.8
, pp. 1265-1271
-
-
Seals, R.M.1
Hansen, J.2
Gredal, O.3
Weisskopf, M.G.4
-
45
-
-
79955777846
-
Proposed criteria for familial amyotrophic lateral sclerosis
-
21208036
-
Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(3):157-9.
-
(2011)
Amyotroph Lateral Scler
, vol.12
, Issue.3
, pp. 157-159
-
-
Byrne, S.1
Bede, P.2
Elamin, M.3
Kenna, K.4
Lynch, C.5
McLaughlin, R.6
-
46
-
-
84865071988
-
Evidence for an oligogenic basis of amyotrophic lateral sclerosis
-
22645277
-
van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3776-84.
-
(2012)
Hum Mol Genet
, vol.21
, Issue.17
, pp. 3776-3784
-
-
Van Blitterswijk, M.1
Van Es, M.A.2
Hennekam, E.A.3
Dooijes, D.4
Van Rheenen, W.5
Medic, J.6
-
47
-
-
79955787123
-
Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis
-
21220648
-
Daoud H, Valdmanis PN, Gros-Louis F, Belzil V, Spiegelman D, Henrion E, et al. Resequencing of 29 candidate genes in patients with familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(5):587-93.
-
(2011)
Arch Neurol
, vol.68
, Issue.5
, pp. 587-593
-
-
Daoud, H.1
Valdmanis, P.N.2
Gros-Louis, F.3
Belzil, V.4
Spiegelman, D.5
Henrion, E.6
-
48
-
-
80955178345
-
SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant
-
21621297
-
Luigetti M, Lattante S, Zollino M, Conte A, Marangi G, Del Grande A, et al. SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Neurobiol Aging. 2011;32(10):1924.
-
(2011)
Neurobiol Aging
, vol.32
, Issue.10
, pp. 1924
-
-
Luigetti, M.1
Lattante, S.2
Zollino, M.3
Conte, A.4
Marangi, G.5
Del Grande, A.6
-
49
-
-
0027401203
-
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
-
1:CAS:528:DyaK3sXhvV2hs74%3D 8446170
-
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59-62.
-
(1993)
Nature
, vol.362
, Issue.6415
, pp. 59-62
-
-
Rosen, D.R.1
Siddique, T.2
Patterson, D.3
Figlewicz, D.A.4
Sapp, P.5
Hentati, A.6
-
50
-
-
40349102131
-
Prevalence of SOD1 mutations in the Italian ALS population
-
1:STN:280:DC%2BD1c7gvFCrug%3D%3D 18268245
-
Chio A, Traynor BJ, Lombardo F, Fimognari M, Calvo A, Ghiglione P, et al. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70(7):533-7.
-
(2008)
Neurology
, vol.70
, Issue.7
, pp. 533-537
-
-
Chio, A.1
Traynor, B.J.2
Lombardo, F.3
Fimognari, M.4
Calvo, A.5
Ghiglione, P.6
-
51
-
-
41149180753
-
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BD1cXjsVamtbo%3D 18309045
-
Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668-72.
-
(2008)
Science
, vol.319
, Issue.5870
, pp. 1668-1672
-
-
Sreedharan, J.1
Blair, I.P.2
Tripathi, V.B.3
Hu, X.4
Vance, C.5
Rogelj, B.6
-
52
-
-
61349162349
-
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6
-
1:CAS:528:DC%2BD1MXit1eltbs%3D 19251628
-
Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208-11.
-
(2009)
Science
, vol.323
, Issue.5918
, pp. 1208-1211
-
-
Vance, C.1
Rogelj, B.2
Hortobagyi, T.3
De Vos, K.J.4
Nishimura, A.L.5
Sreedharan, J.6
-
53
-
-
80054837386
-
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
-
Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257-68. This paper represents a real turning point in the genetics of ALS.
-
(2011)
Neuron.
, vol.72
, Issue.2
, pp. 257-268
-
-
Renton, A.E.1
Majounie, E.2
Waite, A.3
Simon-Sanchez, J.4
Rollinson, S.5
Gibbs, J.R.6
-
54
-
-
80054832080
-
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
-
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-56. This paper represents a real turning point in the genetics of ALS.
-
(2011)
Neuron.
, vol.72
, Issue.2
, pp. 245-256
-
-
Dejesus-Hernandez, M.1
Mackenzie, I.R.2
Boeve, B.F.3
Boxer, A.L.4
Baker, M.5
Rutherford, N.J.6
-
55
-
-
67049155508
-
Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis
-
2683883 1:CAS:528:DC%2BD1MXntlyiu70%3D 19451621
-
Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, et al. Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2009;106(22):9004-9.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.22
, pp. 9004-9009
-
-
Landers, J.E.1
Melki, J.2
Meininger, V.3
Glass, J.D.4
Van Den Berg, L.H.5
Van Es, M.A.6
-
56
-
-
84868656581
-
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
-
22922411
-
Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012;18(9):1418-22.
-
(2012)
Nat Med
, vol.18
, Issue.9
, pp. 1418-1422
-
-
Van Hoecke, A.1
Schoonaert, L.2
Lemmens, R.3
Timmers, M.4
Staats, K.A.5
Laird, A.S.6
-
57
-
-
84868133881
-
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1
-
22959728 e7-19
-
Ahmeti KB, Ajroud-Driss S, Al-Chalabi A, Andersen PM, Armstrong J, Birve A, et al. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging. 2013;34(1):357. e7-19.
-
(2013)
Neurobiol Aging
, vol.34
, Issue.1
, pp. 357
-
-
Ahmeti, K.B.1
Ajroud-Driss, S.2
Al-Chalabi, A.3
Andersen, P.M.4
Armstrong, J.5
Birve, A.6
-
58
-
-
78649632679
-
An estimate of amyotrophic lateral sclerosis heritability using twin data
-
2988617 1:STN:280:DC%2BC3cbnsV2ntA%3D%3D 20861059
-
Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81(12):1324-6.
-
(2010)
J Neurol Neurosurg Psychiatry
, vol.81
, Issue.12
, pp. 1324-1326
-
-
Al-Chalabi, A.1
Fang, F.2
Hanby, M.F.3
Leigh, P.N.4
Shaw, C.E.5
Ye, W.6
-
59
-
-
0034574407
-
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
-
1:STN:280:DC%2BD3Mvhs1Ghsg%3D%3D 11464847
-
Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-9.
-
(2000)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.1
, Issue.5
, pp. 293-299
-
-
Brooks, B.R.1
Miller, R.G.2
Swash, M.3
Munsat, T.L.4
-
60
-
-
80755146087
-
Biomarkers in amyotrophic lateral sclerosis: Opportunities and limitations
-
1:CAS:528:DC%2BC3MXhsVahur3N 21989244
-
Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat Rev Neurol. 2011;7(11):631-8.
-
(2011)
Nat Rev Neurol
, vol.7
, Issue.11
, pp. 631-638
-
-
Bowser, R.1
Turner, M.R.2
Shefner, J.3
-
61
-
-
79952486262
-
Amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC3MXjtFWgsL8%3D 21296405
-
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-55.
-
(2011)
Lancet
, vol.377
, Issue.9769
, pp. 942-955
-
-
Kiernan, M.C.1
Vucic, S.2
Cheah, B.C.3
Turner, M.R.4
Eisen, A.5
Hardiman, O.6
-
62
-
-
84884497586
-
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
-
3779219 1:CAS:528:DC%2BC3sXhsFeiur3M 24073237
-
Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One. 2013;8(9):e75091.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. 75091
-
-
Gaiottino, J.1
Norgren, N.2
Dobson, R.3
Topping, J.4
Nissim, A.5
Malaspina, A.6
-
63
-
-
84875225946
-
Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
-
23117489
-
Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, et al. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(4):467-72.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, Issue.4
, pp. 467-472
-
-
Boylan, K.B.1
Glass, J.D.2
Crook, J.E.3
Yang, C.4
Thomas, C.S.5
Desaro, P.6
-
64
-
-
84869498484
-
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression
-
1:STN:280:DC%2BC38jgtFGitw%3D%3D 22680408
-
Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, Leo A, et al. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol. 2012;19(12):1561-7.
-
(2012)
Eur J Neurol
, vol.19
, Issue.12
, pp. 1561-1567
-
-
Tortelli, R.1
Ruggieri, M.2
Cortese, R.3
D'Errico, E.4
Capozzo, R.5
Leo, A.6
-
65
-
-
84923083893
-
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis
-
24750431
-
Tortelli R, Copetti M, Ruggieri M, Cortese R, Capozzo R, Leo A, et al. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis. Eur J Neurol. 2014;22:215-8.
-
(2014)
Eur J Neurol
, vol.22
, pp. 215-218
-
-
Tortelli, R.1
Copetti, M.2
Ruggieri, M.3
Cortese, R.4
Capozzo, R.5
Leo, A.6
-
66
-
-
84927587746
-
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: Insights from a longitudinal study
-
Lu CH, Petzold A, Topping J, Allen K, Macdonald-Wallis C, Clarke J, et al. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry. 2014.
-
(2014)
J Neurol Neurosurg Psychiatry.
-
-
Ch, L.1
Petzold, A.2
Topping, J.3
Allen, K.4
Macdonald-Wallis, C.5
Clarke, J.6
-
67
-
-
84864014087
-
Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS
-
3397981 1:CAS:528:DC%2BC38XhtVyis7nM 22815892
-
Lu CH, Petzold A, Kalmar B, Dick J, Malaspina A, Greensmith L. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS. PLoS One. 2012;7(7):e40998.
-
(2012)
PLoS One
, vol.7
, Issue.7
, pp. 40998
-
-
Lu, C.H.1
Petzold, A.2
Kalmar, B.3
Dick, J.4
Malaspina, A.5
Greensmith, L.6
-
68
-
-
77951484446
-
The application of biomarkers in clinical trials for motor neuron disease
-
2897051 1:CAS:528:DC%2BC3cXkvVKqt7k%3D 20406070
-
Ganesalingam J, Bowser R. The application of biomarkers in clinical trials for motor neuron disease. Biomark Med. 2010;4(2):281-97.
-
(2010)
Biomark Med
, vol.4
, Issue.2
, pp. 281-297
-
-
Ganesalingam, J.1
Bowser, R.2
-
69
-
-
36248939088
-
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: Impact of SOD1 genotype
-
1:STN:280:DC%2BD2snptFejug%3D%3D 17903209
-
Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen PM. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol. 2007;14(12):1329-33.
-
(2007)
Eur J Neurol
, vol.14
, Issue.12
, pp. 1329-1333
-
-
Zetterberg, H.1
Jacobsson, J.2
Rosengren, L.3
Blennow, K.4
Andersen, P.M.5
-
70
-
-
70350782376
-
Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: Evaluation of blood pNF-H as a potential ALS biomarker
-
1:CAS:528:DC%2BD1MXhsVyrsbfJ 19765193
-
Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, et al. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem. 2009;111(5):1182-91.
-
(2009)
J Neurochem
, vol.111
, Issue.5
, pp. 1182-1191
-
-
Boylan, K.1
Yang, C.2
Crook, J.3
Overstreet, K.4
Heckman, M.5
Wang, Y.6
-
71
-
-
78751705193
-
A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect
-
1:CAS:528:DC%2BC3MXhtVKlsrs%3D 21134399
-
Lu CH, Kalmar B, Malaspina A, Greensmith L, Petzold A. A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect. J Neurosci Methods. 2011;195(2):143-50.
-
(2011)
J Neurosci Methods
, vol.195
, Issue.2
, pp. 143-150
-
-
Lu, C.H.1
Kalmar, B.2
Malaspina, A.3
Greensmith, L.4
Petzold, A.5
-
72
-
-
84896718498
-
Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis
-
24078718
-
Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G, et al. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2014;85(3):274-8.
-
(2014)
J Neurol Neurosurg Psychiatry
, vol.85
, Issue.3
, pp. 274-278
-
-
Puentes, F.1
Topping, J.2
Kuhle, J.3
Van Der Star, B.J.4
Douiri, A.5
Giovannoni, G.6
-
73
-
-
84929184542
-
Disease origin and progression in amyotrophic lateral sclerosis: An immunology perspective
-
Malaspina A, Puentes F, Amor S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol. 2014.
-
(2014)
Int Immunol.
-
-
Malaspina, A.1
Puentes, F.2
Amor, S.3
-
74
-
-
84871988603
-
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
-
3569654 1:CAS:528:DC%2BC3sXntFWl 23143995
-
Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5(1):64-79.
-
(2013)
EMBO Mol Med
, vol.5
, Issue.1
, pp. 64-79
-
-
Henkel, J.S.1
Beers, D.R.2
Wen, S.3
Rivera, A.L.4
Toennis, K.M.5
Appel, J.E.6
-
75
-
-
85056060035
-
Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis
-
2627516 1:CAS:528:DC%2BD1cXhtlOnsbbP 19452011
-
Qureshi M, Brown Jr RH, Rogers JT, Cudkowicz ME. Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol J. 2008;2:51-4.
-
(2008)
Open Neurol J
, vol.2
, pp. 51-54
-
-
Qureshi, M.1
Brown, Jr.R.H.2
Rogers, J.T.3
Cudkowicz, M.E.4
-
76
-
-
84866163028
-
A pilot trial of pioglitazone HCl and tretinoin in ALS: Cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression
-
3395264 22830016
-
Levine TD, Bowser R, Hank NC, Gately S, Stephan D, Saperstein DS, et al. A pilot trial of pioglitazone HCl and tretinoin in ALS: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression. Neurol Res Int. 2012;2012:582075.
-
(2012)
Neurol Res Int
, vol.2012
, pp. 582075
-
-
Levine, T.D.1
Bowser, R.2
Hank, N.C.3
Gately, S.4
Stephan, D.5
Saperstein, D.S.6
-
77
-
-
84862889813
-
Neuroimaging in amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC38XptFWhtrY%3D 22731907
-
Turner MR, Agosta F, Bede P, Govind V, Lule D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6(3):319-37.
-
(2012)
Biomark Med
, vol.6
, Issue.3
, pp. 319-337
-
-
Turner, M.R.1
Agosta, F.2
Bede, P.3
Govind, V.4
Lule, D.5
Verstraete, E.6
-
78
-
-
84919396489
-
Neuroimaging in amyotrophic lateral sclerosis: Insights into structural and functional changes
-
25453462
-
Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228-40.
-
(2014)
Lancet Neurol
, vol.13
, Issue.12
, pp. 1228-1240
-
-
Chio, A.1
Pagani, M.2
Agosta, F.3
Calvo, A.4
Cistaro, A.5
Filippi, M.6
-
79
-
-
84906666492
-
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
-
Menke RA, Korner S, Filippini N, Douaud G, Knight S, Talbot K, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain. 2014;137(Pt 9):2546-55. This longitudinal analysis revealed progressive and widespread changes in the grey matter in contrast with a limited white matter pathology progression, with implications for the development of effective imaging biomarkers.
-
(2014)
Brain.
, vol.137
, Issue.PART 9
, pp. 2546-2555
-
-
Menke, R.A.1
Korner, S.2
Filippini, N.3
Douaud, G.4
Knight, S.5
Talbot, K.6
-
80
-
-
84876253929
-
Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes
-
23427327
-
Mioshi E, Lillo P, Yew B, Hsieh S, Savage S, Hodges JR, et al. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013;80(12):1117-23.
-
(2013)
Neurology
, vol.80
, Issue.12
, pp. 1117-1123
-
-
Mioshi, E.1
Lillo, P.2
Yew, B.3
Hsieh, S.4
Savage, S.5
Hodges, J.R.6
-
81
-
-
78649344523
-
Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies
-
20929296
-
Chen Z, Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler. 2010;11(6):549-54.
-
(2010)
Amyotroph Lateral Scler
, vol.11
, Issue.6
, pp. 549-554
-
-
Chen, Z.1
Ma, L.2
-
82
-
-
84894226663
-
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis
-
3835750 24278317
-
Mezzapesa DM, D'Errico E, Tortelli R, Distaso E, Cortese R, Tursi M, et al. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS One. 2013;8(11):e80748.
-
(2013)
PLoS One
, vol.8
, Issue.11
, pp. 80748
-
-
Mezzapesa, D.M.1
D'Errico, E.2
Tortelli, R.3
Distaso, E.4
Cortese, R.5
Tursi, M.6
-
83
-
-
84885177054
-
Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis
-
23992619
-
Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, et al. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(1):240-6.
-
(2014)
Neurobiol Aging
, vol.35
, Issue.1
, pp. 240-246
-
-
Schuster, C.1
Kasper, E.2
Dyrba, M.3
Machts, J.4
Bittner, D.5
Kaufmann, J.6
-
84
-
-
2442660249
-
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)
-
1:STN:280:DC%2BD2c3mtVaqsA%3D%3D 15159473
-
Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004;62(10):1753-7.
-
(2004)
Neurology
, vol.62
, Issue.10
, pp. 1753-1757
-
-
Kaufmann, P.1
Pullman, S.L.2
Shungu, D.C.3
Chan, S.4
Hays, A.P.5
Del Bene, M.L.6
-
85
-
-
84882447354
-
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy
-
4382938 23797905
-
Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RA, Mohamed MA, et al. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol. 2013;70(8):1009-16.
-
(2013)
JAMA Neurol
, vol.70
, Issue.8
, pp. 1009-1016
-
-
Foerster, B.R.1
Pomper, M.G.2
Callaghan, B.C.3
Petrou, M.4
Edden, R.A.5
Mohamed, M.A.6
-
86
-
-
84861888808
-
A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis
-
21621298
-
Li J, Pan P, Song W, Huang R, Chen K, Shang H. A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(8):1833-8.
-
(2012)
Neurobiol Aging
, vol.33
, Issue.8
, pp. 1833-1838
-
-
Li, J.1
Pan, P.2
Song, W.3
Huang, R.4
Chen, K.5
Shang, H.6
-
87
-
-
84881325362
-
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: A systematic review and individual patient data meta-analysis
-
Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Churchill CL, et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol. 2013;20(9):1099-106. This individual patient data meta-analysis, reviewing all DTI studies, reported diagnostic accuracy of cerebral corticospinal tract fractional anisotropy in ALS subjects.
-
(2013)
Acad Radiol.
, vol.20
, Issue.9
, pp. 1099-1106
-
-
Foerster, B.R.1
Dwamena, B.A.2
Petrou, M.3
Carlos, R.C.4
Callaghan, B.C.5
Churchill, C.L.6
-
88
-
-
81555226597
-
Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: A diffusion tensor tractography study
-
1:STN:280:DC%2BC3MbptlyktQ%3D%3D 22016410
-
Sarro L, Agosta F, Canu E, Riva N, Prelle A, Copetti M, et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am J Neuroradiol. 2011;32(10):1866-72.
-
(2011)
AJNR Am J Neuroradiol
, vol.32
, Issue.10
, pp. 1866-1872
-
-
Sarro, L.1
Agosta, F.2
Canu, E.3
Riva, N.4
Prelle, A.5
Copetti, M.6
-
89
-
-
84895526329
-
Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis
-
24219347
-
Branco LM, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, Franca Jr MC. Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1-2):93-7.
-
(2014)
Amyotroph Lateral Scler Frontotemporal Degener
, vol.15
, Issue.1-2
, pp. 93-97
-
-
Branco, L.M.1
De Albuquerque, M.2
De Andrade, H.M.3
Bergo, F.P.4
Nucci, A.5
Franca, Jr.M.C.6
-
90
-
-
34247181189
-
Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis
-
2117814 1:STN:280:DC%2BD2s3it12quw%3D%3D 17030586
-
Valsasina P, Agosta F, Benedetti B, Caputo D, Perini M, Salvi F, et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(5):480-4.
-
(2007)
J Neurol Neurosurg Psychiatry
, vol.78
, Issue.5
, pp. 480-484
-
-
Valsasina, P.1
Agosta, F.2
Benedetti, B.3
Caputo, D.4
Perini, M.5
Salvi, F.6
-
91
-
-
79955769734
-
Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC3MXls1Kgsbc%3D 21143004
-
Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(3):185-91.
-
(2011)
Amyotroph Lateral Scler
, vol.12
, Issue.3
, pp. 185-191
-
-
Carew, J.D.1
Nair, G.2
Pineda-Alonso, N.3
Usher, S.4
Hu, X.5
Benatar, M.6
-
92
-
-
77956056987
-
Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis
-
20600964
-
Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M. Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage. 2010;53(2):576-83.
-
(2010)
Neuroimage
, vol.53
, Issue.2
, pp. 576-583
-
-
Nair, G.1
Carew, J.D.2
Usher, S.3
Lu, D.4
Hu, X.P.5
Benatar, M.6
-
93
-
-
84904506447
-
Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis
-
4207190 24604691
-
Schmidt R, Verstraete E, de Reus MA, Veldink JH, van den Berg LH, van den Heuvel MP. Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp. 2014;35(9):4386-95.
-
(2014)
Hum Brain Mapp
, vol.35
, Issue.9
, pp. 4386-4395
-
-
Schmidt, R.1
Verstraete, E.2
De Reus, M.A.3
Veldink, J.H.4
Van Den Berg, L.H.5
Van Den Heuvel, M.P.6
-
94
-
-
0033765916
-
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil
-
11050028
-
Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain. 2000;123(Pt 11):2289-96.
-
(2000)
Brain
, vol.123
, Issue.PART 11
, pp. 2289-2296
-
-
Lloyd, C.M.1
Richardson, M.P.2
Brooks, D.J.3
Al-Chalabi, A.4
Leigh, P.N.5
-
95
-
-
84919396244
-
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC2cXhsFert7fJ 25122207
-
Pagani M, Chio A, Valentini MC, Oberg J, Nobili F, Calvo A, et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83(12):1067-74.
-
(2014)
Neurology
, vol.83
, Issue.12
, pp. 1067-1074
-
-
Pagani, M.1
Chio, A.2
Valentini, M.C.3
Oberg, J.4
Nobili, F.5
Calvo, A.6
-
96
-
-
0028097839
-
A controlled trial of riluzole in amyotrophic lateral sclerosis ALS/Riluzole Study Group
-
1:STN:280:DyaK2c7jsVWnsg%3D%3D 8302340
-
Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis ALS/Riluzole Study Group. N Engl J Med. 1994;330(9):585-91.
-
(1994)
N Engl J Med
, vol.330
, Issue.9
, pp. 585-591
-
-
Bensimon, G.1
Lacomblez, L.2
Meininger, V.3
-
97
-
-
0029977337
-
Dose-ranging study of riluzole in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis/Riluzole Study Group II
-
1:CAS:528:DyaK28XjvVSntb8%3D 8676624
-
Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347(9013):1425-31.
-
(1996)
Lancet
, vol.347
, Issue.9013
, pp. 1425-1431
-
-
Lacomblez, L.1
Bensimon, G.2
Leigh, P.N.3
Guillet, P.4
Meininger, V.5
-
98
-
-
0030441578
-
Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)
-
9128396
-
Yanagisawa N, Shindo M. Neuroprotective therapy for amyotrophic lateral sclerosis (ALS). Rinsho Shinkeigaku. 1996;36(12):1329-30.
-
(1996)
Rinsho Shinkeigaku
, vol.36
, Issue.12
, pp. 1329-1330
-
-
Yanagisawa, N.1
Shindo, M.2
-
99
-
-
0036257090
-
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BD38XltFaqs7g%3D 12021952
-
Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P, Meininger V. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol. 2002;249(5):609-15.
-
(2002)
J Neurol
, vol.249
, Issue.5
, pp. 609-615
-
-
Bensimon, G.1
Lacomblez, L.2
Delumeau, J.C.3
Bejuit, R.4
Truffinet, P.5
Meininger, V.6
-
100
-
-
29244439896
-
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride]
-
1:CAS:528:DC%2BD28XhsleqsQ%3D%3D 16188953
-
Danzeisen R, Schwalenstoecker B, Gillardon F, Buerger E, Krzykalla V, Klinder K, et al. Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride]. J Pharmacol Exp Ther. 2006;316(1):189-99.
-
(2006)
J Pharmacol Exp Ther
, vol.316
, Issue.1
, pp. 189-199
-
-
Danzeisen, R.1
Schwalenstoecker, B.2
Gillardon, F.3
Buerger, E.4
Krzykalla, V.5
Klinder, K.6
-
101
-
-
84856101199
-
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC3MXhsV2gtL%2FO 22101764
-
Cudkowicz M, Bozik ME, Ingersoll EW, Miller R, Mitsumoto H, Shefner J, et al. The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med. 2011;17(12):1652-6.
-
(2011)
Nat Med
, vol.17
, Issue.12
, pp. 1652-1656
-
-
Cudkowicz, M.1
Bozik, M.E.2
Ingersoll, E.W.3
Miller, R.4
Mitsumoto, H.5
Shefner, J.6
-
102
-
-
84885388013
-
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): A randomised, double-blind, phase 3 trial
-
1:CAS:528:DC%2BC3sXhsV2mtL3I 24067398
-
Cudkowicz ME, van den Berg LH, Shefner JM, Mitsumoto H, Mora JS, Ludolph A, et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. Lancet Neurol. 2013;12(11):1059-67.
-
(2013)
Lancet Neurol
, vol.12
, Issue.11
, pp. 1059-1067
-
-
Cudkowicz, M.E.1
Van Den Berg, L.H.2
Shefner, J.M.3
Mitsumoto, H.4
Mora, J.S.5
Ludolph, A.6
-
103
-
-
84878883307
-
A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS
-
3707511 1:CAS:528:DC%2BC3sXmt1CmtLo%3D 23602540
-
Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell. 2013;12(6):713-26.
-
(2013)
Cell Stem Cell
, vol.12
, Issue.6
, pp. 713-726
-
-
Yang, Y.M.1
Gupta, S.K.2
Kim, K.J.3
Powers, B.E.4
Cerqueira, A.5
Wainger, B.J.6
-
104
-
-
84875811124
-
Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain
-
3633566 1:CAS:528:DC%2BC3sXktFejt7s%3D 23499447
-
Emborg ME, Liu Y, Xi J, Zhang X, Yin Y, Lu J, et al. Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep. 2013;3(3):646-50.
-
(2013)
Cell Rep
, vol.3
, Issue.3
, pp. 646-650
-
-
Emborg, M.E.1
Liu, Y.2
Xi, J.3
Zhang, X.4
Yin, Y.5
Lu, J.6
-
105
-
-
0034737299
-
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
-
1:CAS:528:DC%2BD3cXisVaitbk%3D 10778856
-
Yamamoto A, Lucas JJ, Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 2000;101(1):57-66.
-
(2000)
Cell
, vol.101
, Issue.1
, pp. 57-66
-
-
Yamamoto, A.1
Lucas, J.J.2
Hen, R.3
-
106
-
-
84873457317
-
Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7
-
3561911 1:CAS:528:DC%2BC3sXhvV2qu78%3D 23197655
-
Furrer SA, Waldherr SM, Mohanachandran MS, Baughn TD, Nguyen KT, Sopher BL, et al. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7. Hum Mol Genet. 2013;22(5):890-903.
-
(2013)
Hum Mol Genet
, vol.22
, Issue.5
, pp. 890-903
-
-
Furrer, S.A.1
Waldherr, S.M.2
Mohanachandran, M.S.3
Baughn, T.D.4
Nguyen, K.T.5
Sopher, B.L.6
-
107
-
-
84862854446
-
Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis
-
1:CAS:528:DC%2BC38XpvFOnsb4%3D 22745481
-
Liu HN, Tjostheim S, Dasilva K, Taylor D, Zhao B, Rakhit R, et al. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci. 2012;32(26):8791-9.
-
(2012)
J Neurosci
, vol.32
, Issue.26
, pp. 8791-8799
-
-
Liu, H.N.1
Tjostheim, S.2
Dasilva, K.3
Taylor, D.4
Zhao, B.5
Rakhit, R.6
-
108
-
-
33746849034
-
Neuroprotective agents for clinical trials in ALS: A systematic assessment
-
1:CAS:528:DC%2BD28XlvFyksr4%3D 16832072
-
Traynor BJ, Bruijn L, Conwit R, Beal F, O'Neill G, Fagan SC, et al. Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology. 2006;67(1):20-7.
-
(2006)
Neurology
, vol.67
, Issue.1
, pp. 20-27
-
-
Traynor, B.J.1
Bruijn, L.2
Conwit, R.3
Beal, F.4
O'Neill, G.5
Fagan, S.C.6
-
109
-
-
82955167994
-
ALS clinical trials: Do enrolled patients accurately represent the ALS population?
-
1:STN:280:DC%2BC3MboslKqtg%3D%3D 21956723
-
Chio A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology. 2011;77(15):1432-7.
-
(2011)
Neurology
, vol.77
, Issue.15
, pp. 1432-1437
-
-
Chio, A.1
Canosa, A.2
Gallo, S.3
Cammarosano, S.4
Moglia, C.5
Fuda, G.6
|